Adhera Therapeutics, Inc. (ATRX)

Adhera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	2	1	0	1	3
Market Cap Growth	-35.16%	107.86%	101.66%	-30.61%	-78.57%	-81.30%
Enterprise Value	11	10	7	7	6	-1
PE Ratio	-	0.80	-0.12	-0.08	-0.05	-0.18
PS Ratio	-	-	-	-	2.58	39.83
PB Ratio	0.00	-0.09	-0.04	-0.03	-0.07	1.04
P/FCF Ratio	-0.16	-1.34	-1.37	-0.77	-0.07	-0.31
P/OCF Ratio	-0.16	-1.34	-1.37	-0.77	-0.07	-0.32
EV/Sales Ratio	-	-	-	-	23.53	-11.60
EV/EBITDA Ratio	-6.30	-6.46	-9.20	-3.40	-0.59	0.08
EV/EBIT Ratio	-3.24	-3.05	-6.18	-2.83	-0.58	0.08
EV/FCF Ratio	-13.52	-7.38	-11.27	-11.51	-0.68	0.09
Debt / Equity Ratio	-0.41	-0.39	-0.27	-0.43	-0.54	0
Debt / EBITDA Ratio	-6.24	-5.31	-8.18	-3.17	-0.53	-
Debt / FCF Ratio	-13.40	-6.07	-10.02	-10.74	-0.61	-
Quick Ratio	0.00	0.00	0.00	0.00	0.00	1.79
Current Ratio	0.00	0.00	0.01	0.00	0.04	2.11
Asset Turnover	0	0	0	0	0.60	0.01
Interest Coverage	-0.45	-0.51	-0.47	-1.15	-17.09	-105.37
Return on Equity (ROE)	9.61%	-10.60%	31.00%	37.50%	127.84%	-572.48%
Return on Assets (ROA)	-5737.66%	2977.22%	-3971.43%	-554000.00%	-3009.52%	-325.92%
Return on Capital (ROIC)	8.26%	11.90%	3.65%	24.09%	248.32%	-539.68%
Earnings Yield	-4169.11%	124.31%	-855.15%	-1227.36%	-1943.27%	-552.09%
FCF Yield	-1332.36%	-74.79%	-73.06%	-130.27%	-1343.37%	-319.15%
Buyback Yield / Dilution	-36.16%	-254.91%	-19.56%	-0.33%	-0.02%	-10.19%
Total Shareholder Return	-36.16%	-254.91%	-19.56%	-0.33%	-0.02%	-10.19%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.